Tirzepatide, being a peptide-based medication, is broken down through proteolysis (protein degradation) rather than hepatic metabolism
For many, that can include the need for a weekly subcutaneous injection
Theres also this recent headline: Which is a touchy subject and I dont want to settle the European regulators investigation (notoriously not overly sensitive about things), but Id venture to say that the psychological impact of obesity and the psychiatric side effects associated with changing body type including dysmorphia and eating disorders probably indicate that this is not a side effect of the drug but rather a side effect of the primary effect of the drug, in a small subset of patients
Many women also report menstrual irregularities after starting GLP-1 treatment, a side effect that has been observed in recent studies exploring hormonal changes linked to GLP-1 medications
Especially when people self-prescribe mega-doses without understanding why they're taking them
It must not be passed to the final consumer of your products